(Q40754999)

23 September 2017

1 reference

title

Structural aspects of serpin inhibition (English)

1 reference

23 September 2017

Schulze AJ

1

1 reference

23 September 2017

Huber R

series ordinal

2

1 reference

23 September 2017

Bode W

series ordinal

3

1 reference

23 September 2017

Engh RA

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

23 September 2017

1 reference

23 September 2017

volume

344

1 reference

23 September 2017

issue

2-3

1 reference

23 September 2017

page(s)

117-124

1 reference

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Crystal structure of ovalbumin as a model for the reactive centre of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Natural protein proteinase inhibitors and their interaction with proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Heparin binding site, conformational change, and activation of antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Proton NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Structure and Biological Role of Vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Ovalbumin and angiotensinogen lack serpin S-R conformational change

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Hormone binding globulins undergo serpin conformational change in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Conformational transition between native and reactive center cleaved forms of alpha 1-antitrypsin by Fourier transform infrared spectroscopy and small-angle neutron scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X‐ray structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Modeling the intact form of the alpha 1-proteinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

An examination of the inhibitory mechanism of serpins by analysing the interaction of trypsin and chymotrypsin with alpha 2-antiplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Inhibitory activity and conformational transition of alpha1-proteinase inhibitor variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Conformational Variability of Chicken Cystatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Evidence for the extent of insertion of the active site loop of intact alpha 1 proteinase inhibitor in beta-sheet A

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmi

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Interaction of human alpha 1-proteinase inhibitor with chymotrypsinogen A and crystallization of a proteolytically modified alpha 1-proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A beta-sheet of the inhibitor during trapping of target proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2894%2900369-6

10.1016/0014-5793(94)00369-6

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference